Clinical Trials Directory

Trials / Sponsors / Newish Technology (Beijing) Co., Ltd.

Newish Technology (Beijing) Co., Ltd.

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingNWRD06 DNA Plasmid for HCC After Curative Resection.
Hepatocellular Carcinoma (HCC)
Phase 22025-12-08
RecruitingNWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
Intraepithelial Neoplasia, Cervical Cancer
N/A2024-06-24
RecruitingNWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
Intraepithelial Neoplasia, Cervical Cancer
N/A2024-06-05
UnknownNWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL
High-grade Squamous Intraepithelial Lesion (HSIL)
Phase 12024-01-25
UnknownNWRD06 DNA Plasmid for HCC After Radical Resection
Hepatocellular Carcinoma
Phase 12023-11-01
UnknownNewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Hepatocellular Carcinoma
Phase 12022-07-26
UnknownClinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive
HSIL of Cervix
N/A2022-03-07
UnknownClinical Trial of Autologous Tcm Immunotherapy in ICC
Cholangiocarcinoma
Phase 22018-05-01